SCI-160
N/A
Report date: 2022/06/01 13:24:57
NME
Base Information
Drug NameSCI-160
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSciSparc Ltd
China Registration ClassN/A
Develop Information
Active CompaniesPolyrizon LtdSciSparc Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A